TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Rating of “Moderate Buy” from Analysts
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among […]
More Stories
From Chaos to Control: How to Organize Your Life Like a Pro
Trying to stay organized, keeping on top of everything, from friends to family, social gatherings, events, and life admin, can...
Best Refrigerators in India 2026: Compare Top Models, Prices and Features
Choosing the right refrigerator is rarely just about price. Factors like energy efficiency, cooling technology, storage design, and smart features...
What to Know About UAE Leaving OPEC
By Owen Evans The United Arab Emirates’ decision to leave the Organization of the Petroleum Exporting Countries (OPEC) next month...
FCC Orders Early Review of Disney’s ABC Station Licenses
By Jill McLaughlin The Federal Communications Commission (FCC) has ordered an early review of license renewals for Disney’s ABC television...
President Trump, First Lady Host King Charles, Queen Camilla for State Dinner
By Travis Gillmore WASHINGTON—First Lady Melania Trump organized a lavish state dinner co-hosted by her husband President Donald Trump in...
US Sanctions 35 Individuals, Entities to Dismantle Iran’s Shadow Banking
By Kimberly Hayek The U.S. Treasury Department on April 28 imposed sanctions on 35 individuals and entities accused of running...